The U.S. Food and Drug Administration’s Center for Veterinary Medicine has completed its evaluation of the pre-market review programmes covering Food Additive Petitions (FAPs) and Generally Recognized as Safe (GRAS) notifications for animal-food ingredients. The review, initiated in 2024, involved public comments, external engagement sessions and internal CVM analysis.
FDA said on September 22 that it is implementing targeted process improvements designed to produce faster and more predictable outcomes while retaining scientific standards. A new CVM policy and procedures manual establishes greater transparency around the GRAS notification evaluation timeline and increases engagement between FDA and submitters.
The development has significance across the animal-nutrition pipeline, including feed additives, enzymes, functional ingredients, minerals, probiotics and other novel nutritional technologies. For companies developing new animal-food ingredients, regulatory predictability can influence development timelines, capital requirements and commercial launch planning.
The broader industry signal is that regulatory process efficiency is becoming part of the competitive landscape for animal-nutrition innovation. Faster review does not mean lower scientific requirements; rather, FDA’s stated objective is greater clarity around how submissions progress through the system.
